Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new trileptal clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on trileptal
- EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Status: Recruiting, Condition Summary: Partial Epilepsy - Oxcarbazepine Versus Placebo in Childhood Autism
Status: Recruiting, Condition Summary: Autism - Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia
Status: Recruiting, Condition Summary: Schizophrenia - Herpes Virus-6 and Epilepsy
Status: Completed, Condition Summary: Epilepsy - Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
Status: Completed, Condition Summary: Seizures; Epilepsy - Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting Conditions
Status: Completed, Condition Summary: Seizures; Epilepsy - Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
Status: Completed, Condition Summary: Epilepsy; Seizures - Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
Status: Recruiting, Condition Summary: Epilepsy; Mental Retardation - Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy
Status: Active, not recruiting, Condition Summary: Epilepsy - Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
Status: Recruiting, Condition Summary: Glioblastoma Multiforme; Gliosarcoma - Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures
Status: Completed, Condition Summary: Epilepsy, Partial Seizures - Pediatric Epilepsy Study
Status: Completed, Condition Summary: Epilepsy; Epilepsies, Partial - The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Adolescents With Impulsivity and Aggressive Behavior in Conduct Disorder This Study is Not Being Conducted in the United States.
Status: Completed, Condition Summary: Conduct Disorder - Pediatric Epilepsy Study
Status: Completed, Condition Summary: Epilepsy - The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.
Status: Completed, Condition Summary: Bipolar Disorder - Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
Status: Completed, Condition Summary: Epilepsy, Partial Seizures - Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-Secretion Caused by Treatment With Antiepileptic Medicine
Status: Withdrawn, Condition Summary: Syndrome of Inappropriate ADH-Secretion - The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)
Status: Completed, Condition Summary: Agitation Aggression in Dementia - Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
Status: Completed, Condition Summary: Bronchial Asthma - Induction of Drug Metabolism: In Vivo Comparison of Carbamazepine and Oxcarbazepine.
Status: Active, not recruiting, Condition Summary: Metabolic Clearance Rate